Asset Management One’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103M Sell
735,649
-53,423
-7% -$7.48M 0.3% 66
2025
Q4
$98.4M Buy
789,072
+61,876
+9% +$7.52M 0.27% 63
2025
Q3
$80.7M Buy
727,196
+13,719
+2% +$1.56M 0.23% 76
2025
Q2
$79.1M Buy
713,477
+8,850
+1% +$942K 0.25% 79
2025
Q1
$79M Buy
704,627
+46,347
+7% +$4.78M 0.27% 67
2024
Q4
$62M Sell
658,280
-6,584
-1% -$593K 0.21% 87
2024
Q3
$55.7M Buy
664,864
+12,017
+2% +$917K 0.2% 95
2024
Q2
$44.8M Sell
652,847
-18,644
-3% -$1.24M 0.17% 108
2024
Q1
$49.2M Sell
671,491
-24,143
-3% -$1.86M 0.19% 100
2023
Q4
$56.4M Sell
695,634
-13,181
-2% -$1.03M 0.23% 89
2023
Q3
$53.1M Sell
708,815
-4,350
-0.6% -$335K 0.24% 79
2023
Q2
$55M Sell
713,165
-69,692
-9% -$5.56M 0.23% 87
2023
Q1
$65M Buy
782,857
+27,227
+4% +$2.26M 0.29% 68
2022
Q4
$64.4M Sell
755,630
-43,867
-5% -$3.47M 0.31% 65
2022
Q3
$49.3M Sell
799,497
-27,094
-3% -$1.71M 0.25% 80
2022
Q2
$51.1M Sell
826,591
-6,100
-0.7% -$378K 0.24% 83
2022
Q1
$49.5M Sell
832,691
-65,137
-7% -$4.16M 0.19% 106
2021
Q4
$66.1M Buy
897,828
+661
+0.1% +$45.5K 0.23% 85
2021
Q3
$62.7M Sell
897,167
-21,897
-2% -$1.54M 0.24% 81
2021
Q2
$63.3M Sell
919,064
-54,284
-6% -$3.62M 0.24% 88
2021
Q1
$62.9M Sell
973,348
-19,489
-2% -$1.26M 0.25% 80
2020
Q4
$56.5M Buy
992,837
+30,959
+3% +$1.87M 0.23% 82
2020
Q3
$60.8M Buy
961,878
+5,805
+0.6% +$403K 0.28% 69
2020
Q2
$73.6M Buy
956,073
+230,653
+32% +$17.7M 0.36% 54
2020
Q1
$54.2M Sell
725,420
-960
-0.1% -$66.3K 0.32% 64
2019
Q4
$47.2M Sell
726,380
-84,048
-10% -$5.47M 0.21% 95
2019
Q3
$51.4M Sell
810,428
-5,001
-0.6% -$327K 0.25% 85
2019
Q2
$55.1M Buy
815,429
+159,903
+24% +$10.5M 0.27% 76
2019
Q1
$42.6M Sell
655,526
-1,486,256
-69% -$98.8M 0.23% 89
2018
Q4
$134M Buy
2,141,782
+28,103
+1% +$1.96M 0.32% 68
2018
Q3
$163M Sell
2,113,679
-29,814
-1% -$2.25M 0.33% 65
2018
Q2
$152M Buy
2,143,493
+33,079
+2% +$2.34M 0.33% 62
2018
Q1
$159M Buy
2,110,414
+19,251
+0.9% +$1.53M 0.36% 56
2017
Q4
$150M Sell
2,091,163
-5,827
-0.3% -$443K 0.33% 61
2017
Q3
$170M Buy
2,096,990
+40,899
+2% +$3.13M 0.4% 51
2017
Q2
$146M Sell
2,056,091
-46,369
-2% -$3.09M 0.37% 54
2017
Q1
$143M Sell
2,102,460
-229,861
-10% -$16.2M 0.37% 53
2016
Q4
$167M Buy
2,332,321
+1,941,144
+496% +$144M 0.43% 47
2016
Q3
$30.6M Sell
391,177
-1,997
-0.5% -$162K 0.45% 44
2016
Q2
$32.4M Sell
393,174
-20,299
-5% -$1.8M 0.49% 37
2016
Q1
$38M Buy
413,473
+17,354
+4% +$1.56M 0.55% 28
2015
Q4
$40.8M Sell
396,119
-32,838
-8% -$3.42M 0.61% 24
2015
Q3
$41.5M Sell
428,957
-4,766
-1% -$529K 0.63% 21
2015
Q2
$50.2M Buy
433,723
+24,270
+6% +$2.65M 0.7% 17
2015
Q1
$41.1M Sell
409,453
-105,191
-20% -$10.7M 0.51% 31
2014
Q4
$49.7M Sell
514,644
-159,563
-24% -$16.5M 0.65% 22
2014
Q3
$72.4M Buy
674,207
+189,954
+39% +$18.6M 1% 8
2014
Q2
$40.2M Sell
484,253
-49,281
-9% -$3.84M 0.6% 25
2014
Q1
$36.9M Buy
533,534
+7,072
+1% +$555K 0.58% 32
2013
Q4
$39.3M Buy
526,462
+31,816
+6% +$2.22M 0.61% 26
2013
Q3
$31.4M Sell
494,646
-98,341
-17% -$5.88M 0.47% 40
2013
Q2
$30.3M Buy
+592,987
New +$30.9M 0.49% 43

Other funds holding GILD

Asset Management One's GILD Position: Q1 2026 in Review

Asset Management One reduced its Gilead Sciences (GILD) stake by 6.8% in Q1 2026, selling an estimated $7.48M and leaving 735,649 shares worth $103M. The position accounts for 0.3% of the portfolio, ranked #66.

Asset Management One first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $170M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Asset Management One held 735,649 shares of Gilead Sciences worth $103M as of Q1 2026.
  • Asset Management One sold 53,423 Gilead Sciences shares in Q1 2026, an estimated $7.48M.
  • Gilead Sciences made up 0.3% of Asset Management One's portfolio in Q1 2026, its #66 holding.
  • Asset Management One first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Asset Management One's Gilead Sciences position peaked at $170M in Q3 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.